Stephen Brannan
Corporate Officer/Principal presso American College of Neuropsychopharmacology
Profilo
Stephen Brannan is a member of several organizations including the International Society for CNS Drug Development, the American College of Neuropsychopharmacology, the International Society For CNS Clinical Trials & Methodology, Alan Aragon's Research Review, and the CNS Summit.
He previously worked as the Vice President-Clinical Research & Medical Affairs at FORUM Pharmaceuticals, Inc. from 2015 to 2016 and as the Head-Neuroscience at Takeda Pharmaceutical Co., Ltd.
from 2011 to 2015.
Currently, he is the Chief Medical Officer at Karuna Therapeutics, Inc. since 2017.
Dr. Brannan holds a doctorate degree from The University of Texas Southwestern Medical Center and an undergraduate degree from Harvard College.
Posizioni attive di Stephen Brannan
| Società | Posizione | Inizio |
|---|---|---|
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Corporate Officer/Principal | - |
| International Society for CNS Drug Development | Corporate Officer/Principal | - |
| International Society For Cns Clinical Trials & Methodology | Corporate Officer/Principal | - |
| Alan Aragon's Research Review | Corporate Officer/Principal | - |
| Cns Summit | Corporate Officer/Principal | - |
Precedenti posizioni note di Stephen Brannan
| Società | Posizione | Fine |
|---|---|---|
| KARA THER | Chief Tech/Sci/R&D Officer | 18/03/2024 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/06/2016 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/08/2015 |
Formazione di Stephen Brannan
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Aziende private | 7 |
|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
| International Society for CNS Drug Development | |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Commercial Services |
| International Society For Cns Clinical Trials & Methodology | |
| Alan Aragon's Research Review | |
| Cns Summit |
- Borsa valori
- Insiders
- Stephen Brannan
